| |
| |
|
| Insider
Information: |
Roshwalb Gur |
| Relationship: |
Director, 10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
175,438 |
|
|
Indirect Shares
|
7,392,237 |
|
|
| Direct
Value |
$33,123 |
|
|
|
Indirect Value
|
$5,699,422 |
|
|
| Total
Shares |
7,567,675 |
|
|
| Total
Value |
$5,732,545 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Akari Therapeutics Plc |
AKTX |
Officer, Director |
2015-01-01 |
175,438 |
|
0 |
Premium* |
|
|
Viracta Therapeutics Ord Shs |
VIRX |
Director, 10% Owner |
|
0 |
2021-02-24 |
7,392,237 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
2 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
2 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
